Article ID Journal Published Year Pages File Type
10970310 Vaccine 2009 6 Pages PDF
Abstract
Finally, we conclude that, nanoparticle adjuvant IMS 3012 could be a possible alternative to the emulsion adjuvants for primary phase of immunization in antivenom preparation considering its better immunopotentiation capacity and safety in donor animals.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , ,